Zydus Wellness Limited
ZYDUSWELL · General/Diversified · NSE
₹501
Current Market Price
Fair Value (DCF)
₹148
Margin of Safety
-70.5%
Updated just now
YieldIQ Score
43/100
Piotroski F-Score
6/9
Economic Moat
Narrow
Confidence
34%
ROE
6.1%
Debt/Equity
0.00
WACC
12.8%
Market Cap
₹0.16 Lakh Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
6.5%
Return on capital employed
EV / EBITDA
37.9×
Enterprise multiple
Debt / EBITDA
0.4×
Leverage vs earnings
Interest Coverage
31.9×
EBIT covers interest
Current Ratio
1.48×
Short-term liquidity
Asset Turnover
0.49×
Revenue per ₹ of assets
Revenue CAGR (3Y)
—
3-year revenue growth
Revenue CAGR (5Y)
11.3%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹501.3
Bear case
₹91.16
MoS -449.9%
Base case
₹148.05
MoS -238.6%
Bull case
₹183.51
MoS -173.2%
Ratio Trends
ZYDUSWELL · last 4 annual periods
ROE
6.1%
ROCE
6.8%
Operating Margin
—
Debt / Equity
0.03×
PE
31.8×
EV / EBITDA
30.5×
Historical Financials
ZYDUSWELL · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹1867 Cr | ₹2009 Cr | ₹713 Cr | ₹783 Cr | ₹2691 Cr | +9.6% |
| EBITDA | — | ₹355 Cr | ₹332 Cr | ₹308 Cr | ₹399 Cr | +3.0% |
| EBIT | ₹216 Cr | ₹332 Cr | ₹131 Cr | ₹161 Cr | — | -7.2% |
| PAT | ₹133 Cr | ₹309 Cr | ₹145 Cr | ₹150 Cr | ₹347 Cr | +27.1% |
| EPS (diluted) | ₹20.92 | ₹48.54 | ₹22.84 | ₹23.62 | — | +3.1% |
| CFO | ₹287 Cr | ₹237 Cr | ₹91.7 Cr | ₹246 Cr | ₹380 Cr | +7.3% |
| CapEx | — | — | — | — | ₹-66.3 Cr | — |
| FCF | — | — | — | — | ₹314 Cr | +0.0% |
| Total Assets | — | ₹5692 Cr | ₹5833 Cr | ₹6148 Cr | ₹6442 Cr | +3.1% |
| Total Debt | — | — | ₹293 Cr | ₹324 Cr | ₹188 Cr | -10.4% |
| Shareholders' Equity | — | — | ₹5123 Cr | ₹5358 Cr | ₹5672 Cr | +2.6% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
ZYDUSWELL vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| BIKAJI BIKAJI | — | — | Pending | 13.6% | — |
| LTFOODS LTFOODS | — | — | Pending | 15.7% | — |
| CCL CCL Products (India) Limited | -59.7% | 43 | Data Limited | 15.8% | — |
| AVANTIFEED AVANTIFEED | — | — | Pending | 16.7% | — |
| GODREJAGRO Godrej Agrovet Limited | +15.0% | 40 | Fairly valued | 16.5% | — |
Click a ticker to view its fair-value analysis.
Dividend History
9 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹5.20/sh
Last payout
2025-07-11
₹1.20
Peak payout
₹1.60
Trailing yield
0.24%
Amounts parsed from NSE subject lines; percent-of-face-value declarations are not converted and shown as missing.
Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of ZYDUSWELL →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for ZYDUSWELL →
Compare
Head-to-head with peers
Compare ZYDUSWELL side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse ZYDUSWELLNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.